I

Immuneering Corp
NASDAQ:IMRX

Watchlist Manager
Immuneering Corp
NASDAQ:IMRX
Watchlist
Price: 1.83 USD -3.68% Market Closed
Market Cap: 54.3m USD
Have any thoughts about
Immuneering Corp?
Write Note

Wall Street
Price Targets

IMRX Price Targets Summary
Immuneering Corp

Wall Street analysts forecast IMRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMRX is 11.44 USD with a low forecast of 1.52 USD and a high forecast of 26.25 USD.

Lowest
Price Target
1.52 USD
17% Downside
Average
Price Target
11.44 USD
525% Upside
Highest
Price Target
26.25 USD
1 334% Upside

IMRX Last Price Targets
Immuneering Corp

The latest public price target was made on Apr 2, 2024 by Graig Suvannavejh from Mizuho Securities , who expects IMRX stock to rise by 337% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Graig Suvannavejh
Mizuho Securities
8 USD
Upside 337%
7 months ago
Apr 2, 2024
Immuneering Corporation (IMRX) PT Lowered to $8 at Mizuho, 'maintain our favorable view on IMRX's innovative approach'
StreetInsider
Michael Yee
Jefferies
3 USD
Upside 64%
7 months ago
Mar 15, 2024
Jefferies Downgrades Immuneering Corporation (IMRX) to Hold
StreetInsider
Graig Suvannavejh
Mizuho Securities
Price Target 8 USD
Upside/Downside 337%
View Source
Michael Yee
Jefferies
Price Target 3 USD
Upside/Downside 64%
View Source
Immuneering Corp Competitors:
Price Targets
EXAS
Exact Sciences Corp
62% Upside
206650
EuBiologics Co Ltd
9% Downside
BCRX
BioCryst Pharmaceuticals Inc
89% Upside
INO
Inovio Pharmaceuticals Inc
212% Upside
RXRX
Recursion Pharmaceuticals Inc
36% Upside
87S
Roivant Sciences Ltd
45% Upside
VRTX
Vertex Pharmaceuticals Inc
7% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
24% Upside

Revenue
Forecast

Revenue Estimate
Immuneering Corp

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Immuneering Corp

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Immuneering Corp

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMRX's stock price target?
Price Target
11.44 USD

According to Wall Street analysts, the average 1-year price target for IMRX is 11.44 USD with a low forecast of 1.52 USD and a high forecast of 26.25 USD.

Back to Top